文献速递产科母胎医学

宫颈阴道液蛋白质组学分析识别早产潜在生物标志物

Cervicovaginal fluid proteomic analysis to identify potential biomarkers for preterm birth.
PubMed 文献 · Am J Obstet Gynecol · 2019-11-20

本研究在有自发性早产史的高危孕妇中,采用靶向和鸟枪法蛋白质组学分析宫颈阴道液样本,以识别早期自发性早产(<34周)的生物标志物。靶向蛋白质组学发现5种蛋白质在病例组中相对丰度较高(P=0.02-0.05),1种较低(P=0.03);鸟枪法发现28种蛋白质在病例组中水平升高超过2倍。对5种蛋白质的酶联免疫吸附试验验证未显示病例组与对照组间有统计学显著差异。

要点

  • 靶向蛋白质组学发现5种蛋白质在早产病例中丰度较高(P=0.02-0.05),1种较低(P=0.03)。
  • 鸟枪法蛋白质组学发现28种蛋白质在早产病例中水平升高超过2倍。
  • 对5种蛋白质的ELISA验证未显示早产病例与足月对照间有统计学显著差异。

关键数值与推荐

  • 靶向蛋白质组学中5种蛋白质在病例组两个访视点相对丰度较高,P=0.02-0.05。
  • 靶向蛋白质组学中1种蛋白质在病例组两个访视点相对丰度较低,P=0.03。
  • 鸟枪法蛋白质组学中28种蛋白质在病例组所有3个访视点检测水平高于对照>2倍。
  • 鸟枪法蛋白质组学中1种蛋白质在病例组所有3个访视点检测水平低于对照<0.5倍。
  • ELISA验证(12例病例,19例对照)未显示5种蛋白质在病例组与对照组间有统计学显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 对5种蛋白质的验证ELISA未产生有临床价值的早产生物标志物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Spontaneous preterm birth is a leading cause of neonatal morbidity and mortality. Early identification of at-risk women by reliable screening tests could reduce the spontaneous preterm birth rate, but conventional methods such as obstetrical history and maternal cervical length screening identify only a minority of spontaneous preterm birth cases. Cervicovaginal fluid might prove to be a useful, readily available biological fluid for identifying spontaneous preterm birth biomarkers. OBJECTIVE: The objective of the study was to identify cervicovaginal fluid biomarkers of early spontaneous preterm birth in a high-risk cohort of pregnant women with a history of spontaneous preterm birth using targeted and shotgun proteomic analyses. STUDY DESIGN: A nested case control study (cases were spontaneous preterm birth <34 weeks in the current pregnancy; controls were spontaneous labor and delivery at 39-41 weeks) was performed using cervicovaginal fluid samples collected at 3 study visits (100/7 to 186/7 weeks, 190/7 to 236/7 weeks, and 280/7 to 316/7 weeks). All participants had a history of at least 1 prior spontaneous preterm birth. Targeted proteomic analysis was performed using a stable isotope-labeled proteome derived from endocervical and vaginal mucosal cells. This served as a standard to quantitate candidate protein levels in individual cervicovaginal fluid samples from the second and third study visits using liquid chromatography-multiple reaction monitoring mass spectrometry. The ratio of endogenous peptide area/stable isotope-labeled proteome-derived peptide area was used to measure levels of 42 peptides in 22 proteins. To maximize biomarker discovery in the cervicovaginal fluid samples, shotgun proteomic analysis also was performed utilizing liquid chromatography and ion trap mass spectrometry. A validation study was performed in second-trimester cervicovaginal fluid samples from an independent study group (12 spontaneous preterm birth cases, 19 term delivery controls) using enzyme-linked immunosorbent assay for 5 proteins expressed at higher levels in spontaneous preterm birth cases compared with controls in targeted or shotgun proteomic analyses. RESULTS: For targeted proteomics, cervicovaginal fluid samples from 33 cases and 32 controls at 190/7 to 236/7 weeks and 16 cases and 14 controls at 280/7 to 316/7 weeks from the same pregnancies were analyzed. When samples were compared between cases and controls, the relative abundance of 5 proteins was greater (P = .02-.05) in cases at both visits, while the relative abundance of 1 protein was lower (P = .03) in cases at both visits. For shotgun proteomics analyses, cervicovaginal fluid samples were pooled for 9 spontaneous preterm birth cases and 9 term delivery controls at each study visit. Shotgun proteomics yielded 28 proteins that were detected at levels >2 times higher and 1 protein that was detected at a level <0.5 times lower in spontaneous preterm birth cases compared with controls at all 3 study visits. Validation enzyme-linked immunosorbent assay for 5 proteins that were detected at higher levels in cervicovaginal fluid samples from spontaneous preterm birth cases compared with term delivery controls in proteomics analyses did not demonstrate statistically significant differences between spontaneous preterm birth cases and controls. CONCLUSIONS: Potential biomarkers of spontaneous preterm birth were identified by targeted and shotgun proteomics analyses in cervicovaginal fluid samples from high-risk, asymptomatic women. Many of the proteins detected at higher levels in cervicovaginal fluid samples from spontaneous preterm birth cases are extracellular matrix proteins and/or regulate cell membrane physiology. These proteins have substantial biological interest, but validation enzyme-linked immunosorbent assay for 5 of these proteins did not yield clinically useful biomarkers for spontaneous preterm birth.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Parry S, Leite R, Esplin MS, et al. Cervicovaginal fluid proteomic analysis to identify potential biomarkers for preterm birth. Am J Obstet Gynecol. 2019. PMID: 31758918. doi:10.1016/j.ajog.2019.11.1252

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。